Velan Capital Investment Management’s Ovid Therapeutics OVID Stock Holding History

Velan Capital Investment Management’s Portfolio OVID Stock Details OVID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$355K	Hold	160,000	–	–	0.22%	30
2025 Q4	$261K	Hold	160,000	–	–	0.15%	33
2025 Q3	$208K	Hold	160,000	–	–	0.2%	30
2025 Q2	$52.8K	Buy	160,000 +63,000	+65%	+$19K	0.05%	43
2025 Q1	$30.3K	Buy	97,000 +27,000	+39%	+$16.6K	0.03%	44
2024 Q4	$65.4K	Buy	+70,000	New	+$78.3K	0.06%	34

Other funds holding OVID

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Velan Capital Investment Management's OVID Position: Q1 2026 in Review

Velan Capital Investment Management held its Ovid Therapeutics (OVID) position steady in Q1 2026 at 160,000 shares worth $355K. The position accounts for 0.22% of the portfolio, ranked #30.

Velan Capital Investment Management first reported a position in OVID in Q4 2024 and has held it in 6 quarters since. 103 funds tracked by Wall St. Rank hold OVID as of Q1 2026.

Velan Capital Investment Management held 160,000 shares of Ovid Therapeutics worth $355K as of Q1 2026.
Velan Capital Investment Management left its Ovid Therapeutics share count unchanged in Q1 2026.
Ovid Therapeutics made up 0.22% of Velan Capital Investment Management's portfolio in Q1 2026, its #30 holding.
Velan Capital Investment Management first reported a position in Ovid Therapeutics in Q4 2024 and has held it in 6 quarters since.
103 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2026.

Based on Velan Capital Investment Management's 13F filing for Q1 2026, filed 15 May 2026.